Industry News
Pharmaceutical Industry News

What to Know About the Effects of Ketamine
Matthew Perry’s death was attributed to the effects of high levels of the anesthetic drug, which is increasingly used to treat depression.
Doctors on the Use of Medical Cannabis
Two physicians respond to a front-page article. Also: The children in Gaza; reviving local news; a divide in texting.
Hair-Loss TikTok Offers Community, and Dubious Recommendations
Hair-loss influencers on TikTok say they are destigmatizing a common insecurity. Critics say they are cashing in on a vulnerable audience.
Drugs like Wegovy Can Fix Teenage Obesity, but Young People Don’t Get Them
Pediatricians are hesitating to prescribe medicines like Wegovy, citing their newness and uncertainties around them.
Do Sleeping Pills Work? A Guide to Insomnia Drugs and Their Risks
A guide to the different types of medications for treating insomnia, their risks and when experts recommend using them.
F.D.A. Approves 2 Sickle Cell Treatments, One Using CRISPR Gene Editing
People with the genetic disease have new opportunities to eliminate their symptoms, but the treatments come with obstacles that limit their reach.
New Sickle Cell Therapies Will Be Out of Reach Where They Are Needed Most
There is no clear path for African patients to get access to the treatments, which have multimillion-dollar price tags and are highly complex to manufacture and deliver.
Why We’re Stuck in a Constant Cycle of Drug Shortages
A few simple solutions could save lives and ease the struggles of countless Americans.
Years After Monsanto Deal, Bayer’s Roundup Bills Keep Piling Up
Juries recently awarded plaintiffs more than $2 billion in damages tied to Roundup, the weedkiller that has been linked to cancer. Bayer is fighting back.
CVS Says It Will Change the Way Its Pharmacies Are Paid
The drugstore chain is introducing a model that will compensate pharmacies based on how much they paid for a drug, as well as a set markup and service fee.
¿Un medicamento para que tu perro viva más?
Los fármacos para la longevidad de nuestros compañeros caninos están cada vez más cerca de hacerse realidad. También plantean interrogantes.
Congress Must Act to Eliminate Hepatitis C
Congress has a chance to eliminate hepatitis C in the United States.
Israel-Hamas Truce Appears to Enter Another Day, and More
Plus, how money is flowing out of China and scientists are one step closer to a drug extending the lives of dogs.
Could Longevity Drugs for Dogs Extend Your Pet’s Life?
Longevity drugs for our canine companions are moving closer to reality. They also raise questions about what it might mean to succeed.
This Quiet Blockbuster at the Supreme Court Could Impact All Americans
This term largely revolves around a single question: Will our government retain the capacity to address the most pressing issues of our time?
Thanksgiving Is All About Food. Will Ozempic Make It Better or Worse?
The weight-loss drugs that have swept into the cultural conversation crash into a holiday that’s all about food.
Sickle-Cell Treatment Created With Gene Editing Wins U.K. Approval
The first treatment that relies on CRISPR is expected to receive U.S. approval next month. But it may cost millions of dollars per patient.
Cannabis for Seniors: Why Older Adults Are Opting for Medical Marijuana
Older people are using cannabis more than ever. Here’s what to know about its potential medicinal benefits and side effects as we age.
Amazon to Stop Selling Seven Eyedrops After F.D.A. Warning
The Food and Drug Administration told the online retailer in a letter this week that the products were not approved for sale in the United States.
Zepbound, el nuevo medicamento aprobado por la FDA para perder peso
Este fármaco tiene el mismo compuesto que Mounjaro, el muy solicitado medicamento para la diabetes. Su aprobación por parte de la FDA podría abrir el camino para su cobertura en los seguros médicos.


